{"anticipatedPostingDate":"2026-12","denomUnitsSelected":"Participants","description":"DFS, as assessed by the investigator, is defined as the time from randomization to the first documented local recurrence, or occurrence of distant kidney cancer metastasis(es), or death due to any cause, whichever occurs first. The PD-L1 expression status is based on combined positive score (CPS). If CPS is ≥ 1, PD-L1 expression status is positive and if the CPS is \\<1, PD-L1 expression status is negative.","reportingStatus":"NOT_POSTED","timeFrame":"Up to approximately 72 months","title":"DFS According to Participant Programmed Cell Death-Ligand 1 (PD-L1) Expression Status (Positive, Negative) as Assessed by the Investigator","type":"SECONDARY"}